How has been the historical performance of Tulasee Bio-Eth.?

Answer:Tulasee Bio-Eth. has shown a consistent pattern of zero net sales and other operating income over the past several years, indicating no revenue generation from its operations from March 2019 to March 2025. The total operating income has remained at zero throughout this period. The company's total expenditure, excluding depreciation, has been minimal, with the highest recorded at 0.57 Cr in March 2021, which has since decreased to 0.13 Cr by March 2025. Operating profit (PBDIT) has consistently been negative, with losses recorded at -0.13 Cr in the last three years, following a profit of 0.48 Cr in March 2021. The profit after tax has also remained negative at -0.13 Cr for the last three years, reflecting ongoing financial challenges.

Breakdown:
Tulasee Bio-Eth. has not generated any net sales or other operating income from March 2019 to March 2025, maintaining a total operating income of zero. The total expenditure has shown a slight decline from 0.57 Cr in March 2021 to 0.13 Cr in March 2025. Despite this reduction in expenditure, the company has continued to report negative operating profits, with losses of -0.13 Cr in the last three years, down from a profit of 0.48 Cr in March 2021. The profit after tax has mirrored this trend, remaining at -0.13 Cr since March 2023. The company's total liabilities have increased slightly from 8.18 Cr in March 2020 to 8.22 Cr in March 2025, while total assets have also seen a minor increase, indicating a stagnant financial position with no significant growth or recovery in profitability.